GVHD, graft-versus-host disease.

^aKadmon does not provide medical advice, diagnosis or treatment recommendations. Please consult your healthcare professional if you have any questions about your health or treatment.

^bPatient Terms and Conditions: The Kadmon ASSIST Commercial Co-pay Savings Program provides co-pay/coinsurance support for out-of-pocket costs on REZUROCK® (belumosudil) tablets prescriptions. A yearly maximum benefit applies. Limit one 30-day supply per 30 days. This program is not health insurance. This program is for commercially or privately insured patients only; uninsured or cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state- or federally funded programs, including, but not limited to, Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, TriCare, private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. The co-pay program may not be combined with any other rebate, coupon or offer. Kadmon Pharmaceuticals, LLC, reserves the right to rescind, revoke or amend this offer at any time without further notice. Any savings provided by the co-pay program may vary depending on patients' out-of-pocket costs. Card is valid through December 31 of the year of activation. On January 1 of the following year, the card automatically resets and is subject to annual limits if the prescription benefit remains the same. Upon registration, patients receive all program details.